The risk-value trade-off: price and brand information impact consumers’ intentions to purchase OTC drugs

Background: European countries face fiscal pressure regarding the long-term sustainability of their healthcare system due to increasing levels of public health expenditures and mounting demographic pressures. The promotion of generic drugs is considered to be an efficient means to tackle these chall...

Full description

Bibliographic Details
Main Authors: Aufegger, L. (Author), Bicknell, C. (Author), Darzi, A. (Author), Yanar, C. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2021
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02994nam a2200517Ia 4500
001 10.1186-s40545-020-00293-5
008 220427s2021 CNT 000 0 und d
020 |a 20523211 (ISSN) 
245 1 0 |a The risk-value trade-off: price and brand information impact consumers’ intentions to purchase OTC drugs 
260 0 |b BioMed Central Ltd  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1186/s40545-020-00293-5 
520 3 |a Background: European countries face fiscal pressure regarding the long-term sustainability of their healthcare system due to increasing levels of public health expenditures and mounting demographic pressures. The promotion of generic drugs is considered to be an efficient means to tackle these challenges; however, market diffusion remains slow. The aim of this study was to investigate the impact of price and brand cues on purchase intentions by means of Direct-to-Consumer (DTC) advertising, and to build on the market cue evaluation model by Dodd et al. Methods: Participants rated purchase intentions on six DTC adverts varying in price and brand information, followed by self-reports on purchase intentions, attitudes towards generics, brand loyalty, price consciousness, as well as perceptions of quality, risk and value. Open-ended questions explored attitudes toward generic drugs. Results: Brand information and purchase intentions were mediated by perceived risk and perceived quality, while price information influenced purchase intention through perceptions of quality, risk and value. Consumers’ purchase behaviour was furthermore influenced by unawareness and misconceptions, past experiences, and advertising as a decision-making tool. Conclusions: Advertisements, including price and brand information, are an important tool to improve consumers’ awareness of the availability of different OTC drugs. Practical and theoretical implications are discussed. © 2021, The Author(s). 
650 0 4 |a advertising 
650 0 4 |a Article 
650 0 4 |a attention 
650 0 4 |a attitude to health 
650 0 4 |a behavior 
650 0 4 |a Brand 
650 0 4 |a consumer 
650 0 4 |a decision making 
650 0 4 |a direct-to-consumer advertizing 
650 0 4 |a drug information 
650 0 4 |a drug quality 
650 0 4 |a generic drug 
650 0 4 |a health care cost 
650 0 4 |a health care system 
650 0 4 |a human 
650 0 4 |a misconception 
650 0 4 |a non prescription drug 
650 0 4 |a OTC advertisement 
650 0 4 |a Perceived risk 
650 0 4 |a personal experience 
650 0 4 |a price 
650 0 4 |a Price information 
650 0 4 |a purchase behaviour 
650 0 4 |a Purchase intention 
650 0 4 |a quality 
650 0 4 |a self report 
650 0 4 |a thinking 
650 0 4 |a unawareness 
650 0 4 |a value 
700 1 |a Aufegger, L.  |e author 
700 1 |a Bicknell, C.  |e author 
700 1 |a Darzi, A.  |e author 
700 1 |a Yanar, C.  |e author 
773 |t Journal of Pharmaceutical Policy and Practice